One Drop today touted data from a study published in the Journal of Medical Internet Research showing that people with diabetes using the One Drop mobile app on their iPhone and Apple Watch reduce their hemoglobin A1c by 1.4%, on average.
The N.Y.-based company noted that lowering blood sugar levels can help patients lessen their risk for cardiovascular disease and microvascular complications.
“Study after study shows people using One Drop experience incredible outcomes. They eat fewer carbs, become more active, and experience dramatic results. But with the Apple Watch, results are even better,” Dr. Chandra Osborn, VP of health & behavioral informatics, said in prepared remarks.
The study included self-reported data from 256 people with diabetes who tracked at least two A1c values in the company’s diabetes management app between two and 12 months time.
“Improving A1c by 1.0% or more not only yields better quality of life for our users, but also saves them an estimated $1,324.30 per person in the first year and an estimated $8,128.83 after five years,” founder & CEO Jeff Dachi said in prepared remarks.
“We are using behavioral- and data science-backed approaches to deliver the most accessible, engaging, affordable, and clinically effective digital diabetes self-care platform in market.”
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.